Development of transgenic mouse models of skin carcinogenesis: potential applications.
Greenhalgh
D A
DA
Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030.
Wang
X J
XJ
Dominey
A M
AM
Rothnagel
J A
JA
Roop
D R
DR
D000818:Animals; D002273:Carcinogens; D003043:Cocarcinogenesis; D003433:Crosses, Genetic; D004268:DNA-Binding Proteins; D005786:Gene Expression Regulation; D011905:Genes, ras; D005822:Genetic Vectors; D015603:Keratinocytes / Q000378:metabolism; D007633:Keratins / Q000235:genetics; D051379:Mice; D008822:Mice, Transgenic; D015689:Oncogene Protein p21(ras) / Q000096:biosynthesis / Q000235:genetics; D009856:Oncogene Proteins, Viral / Q000096:biosynthesis / Q000235:genetics; D009928:Organ Specificity; D016760:Proto-Oncogene Proteins c-fos / Q000096:biosynthesis / Q000235:genetics; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000235:genetics
D002273:Carcinogens; D004268:DNA-Binding Proteins; C052603:E6 protein, Human papillomavirus type 18; C052633:E7 protein, Human papillomavirus type 18; D009856:Oncogene Proteins, Viral; D016760:Proto-Oncogene Proteins c-fos; D011993:Recombinant Fusion Proteins; D007633:Keratins; D015689:Oncogene Protein p21(ras)